Britain's medicines regulator said on Friday it had extended approval of the COVID-19 vaccine developed by Pfizer (PFE.N) and BioNTech (22UAy.DE) so it can be used on 12- to 15-year-olds.
Published 4 years ago on Jun 5th 2021, 6:33 am
By Web Desk
"We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer/BioNTech COVID-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk," June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency, said.
She added that it would be up to the Joint Committee on Vaccination and Immunisation to decide whether this age group would come under the vaccine deployment programme.
Courtesy: Reuters
Crackdown in Punjab against illegal possession of lions, 4 people arrested
- ایک گھنٹہ قبل
Six people killed in bus-trailer collision in Muzaffargarh
- 4 گھنٹے قبل
24 killed in heavy rains, flooding in Texas
- 5 گھنٹے قبل
Salaries of govt employees increased by 10pc, allowance by 30pc
- 4 گھنٹے قبل
CTD foils major attack in Taunsa Sharif; Five terrorists eliminated
- 2 گھنٹے قبل
Trump says Iran has not agreed to inspections, give up enrichment
- 3 گھنٹے قبل
Khankandi: PM Shehbaz meets Turkiye, Azerbaijan presidents
- 3 گھنٹے قبل
Drugs worth over Rs9mn seized in anti-smuggling operations
- 3 گھنٹے قبل
Microsoft to shut down office in Pakistan, lay off 5 employees
- 2 گھنٹے قبل
Muharram 9 central processions underway in major cities
- 31 منٹ قبل
Federal govt debt reaches all-time high in Pakistan’s history
- ایک گھنٹہ قبل
Mobile phone service starts shutting down in Karachi
- ایک گھنٹہ قبل
You May Like
Trending
